BioSyent, Inc. (RX.V)
14.61
+0.11
(+0.76%)
CAD |
TSXV |
Apr 29, 14:59
BioSyent Market Cap : 167.98M for April 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arch Biopartners, Inc. | 29.12M |
| Biocure Technology, Inc. | 0.7072M |
| Resverlogix Corp. | 27.30M |
| Microbix Biosystems, Inc. | 34.64M |
| Helix BioPharma Corp. | 156.58M |
Market Cap Related Metrics
| PE Ratio | 18.56 |
| PS Ratio | 3.884 |
| PEG Ratio | 0.6960 |
| Price to Book Value | 4.051 |
| Price to Free Cash Flow | 18.12 |
| Price | 14.61 |
| Earnings Yield | 5.39% |
| PEGY Ratio | 0.6611 |
| Operating PE Ratio | 14.78 |
| Normalized PE Ratio | 18.56 |